Stem Cell-Based Therapies for Liver Diseases: State of the Art and New Perspectives
Millions of patients worldwide suffer from end-stage liver pathologies, whose only curative therapy is liver transplantation (OLT). Given the donor organ shortage, alternatives to OLT have been evaluated, including cell therapies. Hepatocyte transplantation has been attempted to cure metabolic live...
Main Authors: | Anna Chiara Piscaglia, Mariachiara Campanale, Antonio Gasbarrini, Giovanni Gasbarrini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.4061/2010/259461 |
Similar Items
-
Therapeutic Implications of Mesenchymal Stem Cells in Liver Injury
by: Maria Ausiliatrice Puglisi, et al.
Published: (2011-01-01) -
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01) -
Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
by: Mattia Paratore, et al.
Published: (2021-06-01) -
Celiac Disease and Myointimal Proliferation: A Possible Correlation?
by: Giuseppe Merra, et al.
Published: (2008-11-01) -
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
by: Maria Cerreto, et al.
Published: (2021-07-01)